Cargando…

Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position

We have previously reported a series of anilinoquinazoline derivatives as potent and selective biochemical inhibitors of the RET kinase domain. However, these derivatives displayed diminished cellular potency. Herein we describe further optimisation of the series through modification of their physic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jordan, Allan M., Begum, Habiba, Fairweather, Emma, Fritzl, Samantha, Goldberg, Kristin, Hopkins, Gemma V., Hamilton, Niall M., Lyons, Amanda J., March, H. Nikki, Newton, Rebecca, Small, Helen F., Vishwanath, Swamy, Waddell, Ian D., Waszkowycz, Bohdan, Watson, Amanda J., Ogilvie, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896930/
https://www.ncbi.nlm.nih.gov/pubmed/27086121
http://dx.doi.org/10.1016/j.bmcl.2016.03.100
_version_ 1782436049203494912
author Jordan, Allan M.
Begum, Habiba
Fairweather, Emma
Fritzl, Samantha
Goldberg, Kristin
Hopkins, Gemma V.
Hamilton, Niall M.
Lyons, Amanda J.
March, H. Nikki
Newton, Rebecca
Small, Helen F.
Vishwanath, Swamy
Waddell, Ian D.
Waszkowycz, Bohdan
Watson, Amanda J.
Ogilvie, Donald J.
author_facet Jordan, Allan M.
Begum, Habiba
Fairweather, Emma
Fritzl, Samantha
Goldberg, Kristin
Hopkins, Gemma V.
Hamilton, Niall M.
Lyons, Amanda J.
March, H. Nikki
Newton, Rebecca
Small, Helen F.
Vishwanath, Swamy
Waddell, Ian D.
Waszkowycz, Bohdan
Watson, Amanda J.
Ogilvie, Donald J.
author_sort Jordan, Allan M.
collection PubMed
description We have previously reported a series of anilinoquinazoline derivatives as potent and selective biochemical inhibitors of the RET kinase domain. However, these derivatives displayed diminished cellular potency. Herein we describe further optimisation of the series through modification of their physicochemical properties, delivering improvements in cell potency. However, whilst cellular selectivity against key targets could be maintained, combining cell potency and acceptable pharmacokinetics proved challenging.
format Online
Article
Text
id pubmed-4896930
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-48969302016-06-15 Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position Jordan, Allan M. Begum, Habiba Fairweather, Emma Fritzl, Samantha Goldberg, Kristin Hopkins, Gemma V. Hamilton, Niall M. Lyons, Amanda J. March, H. Nikki Newton, Rebecca Small, Helen F. Vishwanath, Swamy Waddell, Ian D. Waszkowycz, Bohdan Watson, Amanda J. Ogilvie, Donald J. Bioorg Med Chem Lett Article We have previously reported a series of anilinoquinazoline derivatives as potent and selective biochemical inhibitors of the RET kinase domain. However, these derivatives displayed diminished cellular potency. Herein we describe further optimisation of the series through modification of their physicochemical properties, delivering improvements in cell potency. However, whilst cellular selectivity against key targets could be maintained, combining cell potency and acceptable pharmacokinetics proved challenging. Elsevier Science Ltd 2016-06-01 /pmc/articles/PMC4896930/ /pubmed/27086121 http://dx.doi.org/10.1016/j.bmcl.2016.03.100 Text en © 2016 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jordan, Allan M.
Begum, Habiba
Fairweather, Emma
Fritzl, Samantha
Goldberg, Kristin
Hopkins, Gemma V.
Hamilton, Niall M.
Lyons, Amanda J.
March, H. Nikki
Newton, Rebecca
Small, Helen F.
Vishwanath, Swamy
Waddell, Ian D.
Waszkowycz, Bohdan
Watson, Amanda J.
Ogilvie, Donald J.
Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title_full Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title_fullStr Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title_full_unstemmed Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title_short Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
title_sort anilinoquinazoline inhibitors of the ret kinase domain—elaboration of the 7-position
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896930/
https://www.ncbi.nlm.nih.gov/pubmed/27086121
http://dx.doi.org/10.1016/j.bmcl.2016.03.100
work_keys_str_mv AT jordanallanm anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT begumhabiba anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT fairweatheremma anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT fritzlsamantha anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT goldbergkristin anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT hopkinsgemmav anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT hamiltonniallm anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT lyonsamandaj anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT marchhnikki anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT newtonrebecca anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT smallhelenf anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT vishwanathswamy anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT waddelliand anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT waszkowyczbohdan anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT watsonamandaj anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position
AT ogilviedonaldj anilinoquinazolineinhibitorsoftheretkinasedomainelaborationofthe7position